AI Mood Market: Stock Dashboard

Company: Anavex Life Sciences Corporation

Sector: Healthcare

Industry: Biotechnology

Country: USA

Exchange: NASD

Index: RUT

P/E: -

EPS (ttm): -0.46

Insider Own: 3.23%

Shs Outstand: 92.67M

Perf Week: -4.15%

Market Cap: 364.20M

Forward P/E: -

EPS next Y: -0.14

Insider Trans: 0.00%

Shs Float: 89.68M

Perf Month: -18.46%

Enterprise Value: 232.45M

PEG: -

EPS next Q: -0.10

Inst Own: 36.63%

Short Float: 22.25%

Perf Quarter: -43.04%

Income: -39.95M

P/S: -

EPS this Y: 25.31%

Inst Trans: -0.65%

Short Ratio: 7.52

Perf Half Y: -61.13%

Sales: 0.00M

P/B: 2.88

EPS next Y Percentage: 65.29%

ROA: -31.08%

Short Interest: 19.95M

Perf YTD: 10.39%

Book/sh: 1.37

P/C: 2.76

EPS next 5Y: -

ROE: -33.63%

52W High: 13.99 -71.91%

Perf Year: -53.60%

Cash/sh: 1.42

P/FCF: -

EPS past 3/5Y: 4.47% -3.79%

ROIC: -31.55%

52W Low: 2.86 37.41%

Perf 3Y: -62.57%

Dividend Est.: -

EV/EBITDA: -

Sales past 3/5Y: - -

Gross Margin: -

Volatility W: 8.48%

Volatility M: 7.22%

Perf 5Y: -70.25%

Dividend TTM: -

EV/Sales: -

EPS Y/Y TTM: 15.81%

Oper. Margin: -

ATR (14): 0.32

Perf 10Y: 4.24%

Dividend Ex-Date: -

Quick Ratio: 20.87

Sales Y/Y TTM: -

Profit Margin: -

RSI (14): 39.66

Recom: 1.67

Dividend Gr. 3/5Y: - -

Current Ratio: 20.87

EPS Q/Q: 55.32%

SMA20: -14.04%

Beta: 1.11

Target Price: 22.00

Payout: -

Debt/Eq: 0.00

Sales Q/Q: -

SMA50: -8.26%

Rel Volume: 0.41

Prev Close: 3.92

Employees: 34

LT Debt/Eq: 0.00

Earnings: Feb 09 BMO

SMA200: -48.58%

Avg Volume: 2.65M

Price: 3.93

IPO: Aug 02, 2006

Option/Short: Yes / Yes

EPS/Sales Surpr.: 51.34% -

Trades:

Volume: 1,078,045

Change: 0.26%

AI Market Mood: Stock Dashboard

AVXL

Fundamental

Technical:

Latest News:

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral

ANVS AVXL LGVN